Post Doctoral Associate
Dr. Dominic Balog-Way is an interdisciplinary social scientist specializing in the management and communication of risks to public health and the environment. He is particularly interested in multi-actor decision making in dynamic public policy environments and improving evidence-informed practice to tackle local and global threats. Specific interests include: transparency, trust, and uncertainty in public policy and practice; risk perception, communication, and decision-making; international and sectoral comparative policy analysis; and contentious public health and environmental tradeoffs from a One Health systems perspective.
Outreach and Extension Focus
Dominic has led international policy-oriented research in a variety of risk-related contexts and policy domains. He presents frequently across North America and Europe at government authorities, international societies, and academic institutions. He is Vice Chair of the Risk Communication speciality group at the Society for Risk Analysis (SRA), co-organiser of the annual Ditchley Group forums on improving benefit-risk communication, and an affiliated researcher at the King’s Centre for Risk Management, King’s College London. He is a member of the Drug Information Association, and Cornell Risk Communication Research Group, and served as Chair of the Risk Policy & Law speciality group at SRA. Before coming to Cornell, Dominic completed a post-doctorate at King’s exploring how regulators in 32 high-income OECD countries use big data to monitor and regulate hospital healthcare quality.
- Balog-Way, D., & McComas, K. A. (2020). COVID-19: Reflections on trust, tradeoffs, and preparedness. Journal of Risk Research.
- Balog-Way, D., Evensen, D., Lofstedt, R., & Bouder, F. (2020). Effects of public trust on behavioural intentions in the pharmaceutical sector: data from six European countries. Journal of Risk Research.
- Balog-Way, D., Evensen, D., & Löfstedt, R. (2020). Pharmaceutical Benefit–Risk Perception and Age Differences<br>in the USA and Germany.
- Balog-Way, D., Blazsin, H., Lofstedt, Ragnar,, & Bouder, F. (2017). Pharmaceutical benefit-risk communication tools: a review of the literature. Drug safety. 40:15--36.
- Balog-Way, D., Bouder, F., Löfstedt, R., & Evensen, D. (2016). Medicines transparency at the European Medicines Agency (EMA) in the new information age: the perspectives of patients. Journal of Risk Research. 19:1185--1215.
- Lofstedt, R., & Balog-Way, D. (2016). Transparency and trust in the European pharmaceutical sector: Outcomes from an experimental study. Journal of Risk Research. 19:1082-1103.
- Bouder, F., Balog-Way, D., Löfstedt, R., & Evensen, D. (2015). Transparency in Europe: a quantitative study. Risk Analysis: an International Journal. 35:1210--1229.
- Balog-Way, D. (2017). Transparency in risk regulation: the case of the European Medicines Agency. King's College London.
Presentations and Activities
- Science Reporting in a Changing Climate: How can we Do Better? Special SRA Event. December 2019. National Press Club, First Amendment Lounge, Washington, DC, USA.
- Bridging the Risk-Science Policy Gap: Are Regulatory Agencies Ready? Society for Risk Analysis’s Annual Meeting. December 2019. SRA. Arlington, VA, USA.
- Talking about My Generation (Part III): Benefit-Risk Communication and Older Adults. 9th Annual Ditchley Group Forum. June 2019. Convento do Espinheiro. Évora, Portugal.
- Can Big Data Improve Healthcare Quality Regulation? An International Comparative Analysis. Health Care Quality and Outcomes (HCQO) Working Group. June 2019. Organisation for Economic Co-Operation and Development (OECD). Paris, France.
- Talking about My Generation: Exploring Benefit-Risk Communication and Older Adults. Drug Information Association Europe’s Annual Meeting. February 2019. DIA. Vienna, Austria.
- Medicines for Older People: The Importance of Experience in Benefit-Risk Decision-Making. 8th Annual Ditchley Group Forum. May 2018. Kerckebosch Castle. Zeist, Netherlands.
- Transparency Policies Across the Atlantic: Our Research Journey. CORS Annual Conference. October 2017. Copenhagen Centre for Regulatory Science (CORS). University of Copenhagen, Copenhagen, Denmark.
- Towards a Sophisticated Framework for Measuring Pharmacovigilance Impact. International Conference on Pharmacoepidemiology. August 2017. ISPE. Palais des Congrés, Montreal, Canada.
- Transparency in Risk Regulation: Towards a Sophisticated Typology. Inaugural Cambridge Risk and Uncertainty Conference. June 2017. Cambridge University. Cambridge, UK.
- Comparing Transparency Policies at the European Food Safety Authority and European Medicines Agency. Constitutionality, Powers and Legitimacy of EU Agencies or Agency-Like Bodies. November 2016. European University Institute. Florence, Italy.